How does ruxolitinib's response compare with azacitidine alone?

How do response rates compare for ruxolitinib + azacitidine versus azacitidine alone?

The provided information doesn’t include the trial results needed to directly compare response outcomes (such as overall response rate, complete response, partial response, or duration of response) for ruxolitinib when given with azacitidine versus azacitidine alone.

What outcomes would you need to compare (and where to find them)?

A side-by-side comparison usually depends on which “response” endpoint you mean. Trials often report:
- Overall response rate (ORR)
- Complete response (CR) and complete remission
- Partial response (PR)
- Hematologic improvement (sometimes)
- Duration of response (DoR)
- Time to response

Without the specific study report or the numeric results for ruxolitinib + azacitidine and azacitidine monotherapy, I can’t state which one had higher response or by how much.

Which study are you referring to?

Different studies (and different patient groups, dosing, and response definitions) can show different results. If you share the trial name (or the paper/meeting abstract) you’re looking at, I can help extract and compare the exact response figures.

If you want, paste the numbers and I’ll compute the comparison

If you paste the ORR/CR/PR (or the table) for:
- ruxolitinib + azacitidine, and
- azacitidine alone,
I’ll calculate the absolute/relative differences and summarize how the responses compare.

Sources: none (the necessary clinical response data wasn’t provided).